Jr. Michael Conick Hanley

Insider Reports History

Location
Mountain View, CA
Signature
/s/ Erin R. McQuade, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jr. Michael Conick Hanley:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aeglea BioTherapeutics, Inc. Chief Business Officer Employee Stock Option (right to buy) 500,000 23 Feb 2023 Direct
Alto Neuroscience, Inc. CHIEF OPERATING OFFICER Employee Stock Option (Right to Buy) 131,000 11 Feb 2026 Direct

Insider Reports Filed by Jr. Michael Conick Hanley

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ANRO Alto Neuroscience, Inc. 11 Feb 2026 1 $0 4 CHIEF OPERATING OFFICER 13 Feb 2026, 17:17
ANRO Alto Neuroscience, Inc. 03 Jul 2025 6 $0 4 CHIEF OPERATING OFFICER 08 Jul 2025, 17:22
ANRO Alto Neuroscience, Inc. 05 Feb 2025 1 $0 4 CHIEF OPERATING OFFICER 07 Feb 2025, 16:22
ANRO Alto Neuroscience, Inc. 20 May 2024 1 $0 4 Chief Operating Officer 22 May 2024, 17:19
ANRO Alto Neuroscience, Inc. 20 May 2024 0 $0 3 Chief Operating Officer 22 May 2024, 17:17
SYRE Aeglea BioTherapeutics, Inc. 23 Feb 2023 1 $0 4 Chief Business Officer 24 Feb 2023, 17:22
SYRE Aeglea BioTherapeutics, Inc. 23 Aug 2022 1 $0 4 Chief Business Officer 25 Aug 2022, 19:35
SYRE Aeglea BioTherapeutics, Inc. 08 Jun 2022 1 +$20,022 4 Chief Commercial Officer 10 Jun 2022, 18:24
SYRE Aeglea BioTherapeutics, Inc. 17 Feb 2022 1 $0 4 Chief Commercial Officer 22 Feb 2022, 15:51